Laser-Assisted Hatching May Boost Live Births in Repeated IVF Failure, Meta-Analysis Finds

For couples who endure cycle after cycle of in vitro fertilization only to see high-quality embryos fail to implant, few diagnoses are as frustrating as recurrent implantation failure. The condition, which affects roughly one in ten women undergoing embryo transfer, has long been one of the most contested corners of reproductive medicine, with a crowded field of proposed remedies and little consensus about which, if any, actually work. Now a new systematic review and meta-analysis of randomized controlled trials, published in Reproductive Sciences, offers the most rigorous synthesis to date of one of the most widely used laboratory interventions: laser-assisted hatching, a technique in which embryologists use a precision laser to thin or open the embryo’s outer shell in the hope of easing its escape and attachment to the womb.

The findings, drawn from nine randomized controlled trials encompassing 2,481 women with recurrent implantation failure, are cautiously encouraging. The researchers, led by Mohammadamin Parsaei of Tehran University of Medical Sciences, found that women whose embryos underwent laser-assisted hatching had significantly higher rates of clinical pregnancy, ongoing pregnancy, and live birth compared with women who received no such intervention. Perhaps most strikingly, the technique was associated with a significantly lower rate of miscarriage, and the live birth and miscarriage results carried moderate certainty in the researchers’ formal quality assessment, a level of confidence that is rare in this literature.

To understand why the technique exists at all, one has to look at the biology of the earliest days of embryonic development. Every embryo begins life encased in the zona pellucida, a glycoprotein shell that protects the oocyte and early embryo, mediates sperm recognition, and prevents premature implantation. As the embryo reaches the blastocyst stage, it must hatch from this shell, expanding, contracting, and finally rupturing it before it can make contact with the uterine lining. Scientists have long hypothesized that some embryos, particularly those cultured in the laboratory or derived from older oocytes with hardened or thickened zonae, may struggle to complete this escape, and that a laboratory-assisted exit could tip the balance toward successful implantation.

Assisted hatching began as a micromanipulation procedure in the late 1980s, when researchers first partially opened the zona pellucida to facilitate fertilization and later to aid hatching. Early methods relied on mechanical piercing or acidic chemical drilling, both of which carried risks of embryo damage and required considerable manual skill. The introduction of non-contact diode and ultraviolet lasers in the 1990s transformed the procedure: a focused beam could now thin a precise section of the shell, or drill a controlled opening, in seconds, with minimal handling and reproducible results. Today, laser-assisted hatching is performed in two main variants, zona thinning and zona drilling, and the new analysis examined both approaches in its subgroup analyses.

For the new study, the team searched PubMed, Web of Science, Scopus, and Embase on January 22, 2025, for randomized controlled trials comparing embryo transfer outcomes after laser-assisted hatching against controls specifically in women with recurrent implantation failure. They followed the PRISMA 2020 reporting guidelines, assessed risk of bias with the Cochrane RoB 2 tool, pooled outcomes using random-effects meta-analyses expressed as log odds ratios, and graded the certainty of the evidence with the GRADE framework. Publication bias was probed with funnel plots, Egger’s regression test, and the trim-and-fill method, while subgroup analyses stratified results by mean patient age, overall risk of bias, and the specific hatching technique used.

The headline numbers tell a consistent story. Clinical pregnancy was significantly more likely in the hatched group, with a log odds ratio of 0.643 and a 95 percent confidence interval of 0.267 to 1.019, though the underlying trials showed substantial heterogeneity and the certainty of this evidence was rated very low. Ongoing pregnancy showed a similar pattern, with a log odds ratio of 0.811 and very low certainty. Live birth, the outcome that matters most to patients, was significantly improved with a log odds ratio of 0.519 and remarkably low heterogeneity between studies, earning a moderate certainty rating. Miscarriage was significantly reduced, with a log odds ratio of minus 0.632, zero heterogeneity, and moderate certainty.

Not every result favored the intervention. Implantation rates per transferred embryo did not differ significantly between groups, with a log odds ratio of 0.691 whose confidence interval crossed zero and very high heterogeneity of 87.14 percent, suggesting the trials measured this outcome in markedly different ways. Multiple pregnancy rates per clinical pregnancy were also statistically indistinguishable between groups, with zero heterogeneity and moderate certainty, a finding that will reassure clinicians who have worried that weakening the zona pellucida might encourage the embryo to split into identical twins.

The divergence between the live birth and miscarriage results on one hand and the implantation result on the other is scientifically intriguing. If laser-assisted hatching does not measurably increase the proportion of embryos that implant, yet more pregnancies ultimately end in a take-home baby and fewer end in miscarriage, one possible interpretation is that the technique benefits embryos that would otherwise implant abnormally or fail shortly after attachment. The authors themselves, however, urge restraint, noting that the heterogeneity observed across trials and the generally low quality of the available studies mean these conclusions remain provisional, and that high-quality, large-scale randomized controlled trials are needed to confirm them.

The new analysis arrives amid a shifting regulatory and clinical landscape. The American Society for Reproductive Medicine’s 2022 guideline on assisted hatching concluded that the procedure should not be offered routinely or even as a treatment for patients with an anticipated poor prognosis, citing insufficient evidence of benefit. A 2021 Cochrane review of assisted hatching across all IVF and ICSI patients similarly found no clear benefit and raised concerns about possible harms. Yet those syntheses pooled broad populations, including many patients with no implantation problems at all, which may have diluted any genuine effect in the subgroup that matters. By restricting the analysis to women with documented recurrent implantation failure, the new study tests a more focused hypothesis, and its positive live birth finding stands in meaningful tension with the earlier, broader reviews.

For the roughly ten percent of IVF patients who experience repeated implantation failure, the practical takeaway is one of measured hope rather than a change in standard care. The evidence now suggests that laser-assisted hatching, a quick and technically straightforward laboratory procedure, may improve the odds of a live birth in this difficult population without increasing multiple pregnancies, and that it may reduce the heartbreak of miscarriage. But with several of the key outcomes graded at very low certainty, and with the field still lacking a universally agreed definition of recurrent implantation failure itself, patients and clinicians alike will be watching for the large, well-designed trials that the authors say are now essential. Until then, the laser remains a promising but unproven ally in one of fertility medicine’s most stubborn challenges.

Subject of Research: Laser-assisted hatching and embryo transfer outcomes in patients with recurrent implantation failure

Article Title: Outcomes of Embryo Transfer Following Laser-assisted Hatching in Patients with Recurrent Implantation Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Article References: Parsaei, M., Karimi, E., Seifi, P., Dehghan Tarzjani, M., & Tarafdari, A. (2026). Outcomes of Embryo Transfer Following Laser-assisted Hatching in Patients with Recurrent Implantation Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02219-z

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02219-z

Keywords: laser-assisted hatching, recurrent implantation failure, embryo transfer, in vitro fertilization, meta-analysis, live birth rate, miscarriage, zona pellucida, clinical pregnancy, assisted reproductive technology, randomized controlled trials, reproductive medicine